AstraZeneca
65.31
-0.06 (-0.09%)
At close: Jan 15, 2025, 10:01 AM

AstraZeneca Revenue Breakdown

Quarter Dec 31, 2023Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2019
Enhertu Revenue 955.00M 15.00M 11.00M 13.00M 389.00M
Enhertu Revenue Growth +6266.67% +36.36% -15.38% -96.66% n/a
Bevespi Revenue 43.00M 163.00M 53.00M 56.00M 141.00M
Bevespi Revenue Growth -73.62% +207.55% -5.36% -60.28% n/a
Breztri Revenue 514.00M 331.00M 185.00M 375.00M 377.00M
Breztri Revenue Growth +55.29% +78.92% -50.67% -0.53% n/a
Brilinta Revenue 993.00M 43.00M 62.00M 95.00M 167.00M
Brilinta Revenue Growth +2209.30% -30.65% -34.74% -43.11% n/a
Bydureon Revenue 120.00M 653.00M 396.00M 280.00M 267.00M
Bydureon Revenue Growth -81.62% +64.90% +41.43% +4.87% n/a
Calquence Revenue 1.86B 17.00M 54.00M 3.00M 338.00M
Calquence Revenue Growth +10847.06% -68.52% +1700.00% -99.11% n/a
Daliresp/Daxas Revenue 37.00M 67.00M 18.00M 732.00M 283.00M
Daliresp/Daxas Revenue Growth -44.78% +272.22% -97.54% +158.66% n/a
Farxiga Revenue 4.46B 1.50B 275.00M 320.00M 393.00M
Farxiga Revenue Growth +196.21% +447.27% -14.06% -18.58% n/a
Fasenra Revenue 1.15B 406.00M 230.00M 105.00M 116.00M
Fasenra Revenue Growth +182.51% +76.52% +119.05% -9.48% n/a
Faslodex Revenue 219.00M 78.00M 5.00M 604.00M 333.00M
Faslodex Revenue Growth +180.77% +1460.00% -99.17% +81.38% n/a
FluMist Revenue 213.00M 1.08B 374.00M 39.00M 585.00M
FluMist Revenue Growth -80.20% +187.70% +858.97% -93.33% n/a
Imfinzi Revenue 3.16B 46.00M 20.00M 588.00M 784.00M
Imfinzi Revenue Growth +6771.74% +130.00% -96.60% -25.00% n/a
Kanuma Revenue 125.00M 80.00M 47.00M 336.00M 197.00M
Kanuma Revenue Growth +56.25% +70.21% -86.01% +70.56% n/a
Koselugo Revenue 251.00M 100.00M 39.00M 99.00M 20.00M
Koselugo Revenue Growth +151.00% +156.41% -60.61% +395.00% n/a
Lokelma Revenue 312.00M 717.00M 312.00M 167.00M 64.00M
Lokelma Revenue Growth -56.49% +129.81% +86.83% +160.94% n/a
Lynparza Revenue 2.09B 248.00M 30.00M 51.00M 96.00M
Lynparza Revenue Growth +744.35% +726.67% -41.18% -46.88% n/a
Nexium Revenue 697.00M 54.00M 1.00M 680.00M n/a
Nexium Revenue Growth +1190.74% +5300.00% -99.85% n/a n/a
Oncology, Others Revenue 170.00M 65.00M 22.00M 1.31B n/a
Oncology, Others Revenue Growth +161.54% +195.45% -98.32% n/a n/a
Onglyza Revenue 162.00M 53.00M 6.00M 244.00M n/a
Onglyza Revenue Growth +205.66% +783.33% -97.54% n/a n/a
Other, Others Revenue 178.00M 124.00M 15.00M 1.00M n/a
Other, Others Revenue Growth +43.55% +726.67% +1400.00% n/a n/a
Pulmicort Revenue 589.00M 73.00M 50.00M 24.00M n/a
Pulmicort Revenue Growth +706.85% +46.00% +108.33% n/a n/a
Roxadustat Revenue 198.00M 68.00M 223.00M n/a n/a
Roxadustat Revenue Growth +191.18% -69.51% n/a n/a n/a
Saphnelo Revenue 212.00M 164.00M 574.00M n/a n/a
Saphnelo Revenue Growth +29.27% -71.43% n/a n/a n/a
Seloken/Toprol-XL Revenue 476.00M 814.00M 193.00M n/a n/a
Seloken/Toprol-XL Revenue Growth -41.52% +321.76% n/a n/a n/a
Soliris Revenue 2.33B 300.00M 222.00M n/a n/a
Soliris Revenue Growth +677.00% +35.14% n/a n/a n/a
Strensiq Revenue 852.00M 600.00M 2.00M n/a n/a
Strensiq Revenue Growth +42.00% +29900.00% n/a n/a n/a
Symbicort Revenue 1.76B 87.00M 513.00M n/a n/a
Symbicort Revenue Growth +1925.29% -83.04% n/a n/a n/a
Synagis Revenue 459.00M 1.49B 1.60B n/a n/a
Synagis Revenue Growth -69.22% -7.10% n/a n/a n/a
Tagrisso Revenue 4.31B 4.38B 36.00M n/a n/a
Tagrisso Revenue Growth -1.69% +12072.22% n/a n/a n/a
Total Oncology Revenue 12.76B 301.00M 3.00M n/a n/a
Total Oncology Revenue Growth +4140.20% +9933.33% n/a n/a n/a
Total Other medicines Revenue 875.00M 28.00M 18.00M n/a n/a
Total Other medicines Revenue Growth +3025.00% +55.56% n/a n/a n/a
Vaxzevria Revenue 0 233.00M 23.00M n/a n/a
Vaxzevria Revenue Growth -100.00% +913.04% n/a n/a n/a
Zoladex Revenue 719.00M 45.00M 1.00M n/a n/a
Zoladex Revenue Growth +1497.78% +4400.00% n/a n/a n/a
Andexxa Revenue 137.00M 3.00M n/a n/a n/a
Andexxa Revenue Growth +4466.67% n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
Asia, Africa And Australasia Revenue 11.95B 14.37B 13.65B
Asia, Africa And Australasia Revenue Growth -16.88% +5.30% n/a
Australia Revenue 390.00M 571.00M 6.79B
Australia Revenue Growth -31.70% -91.59% n/a
Canada Revenue 967.00M 1.17B 14.89B
Canada Revenue Growth -17.07% -92.17% n/a
China Revenue 5.87B 5.74B 1.21B
China Revenue Growth +2.25% +376.20% n/a
Europe Revenue 9.72B 8.91B n/a
Europe Revenue Growth +9.16% n/a n/a
France Revenue 1.15B 1.11B n/a
France Revenue Growth +4.07% n/a n/a
Italy Revenue 813.00M 735.00M n/a
Italy Revenue Growth +10.61% n/a n/a
Japan Revenue 3.64B 3.99B n/a
Japan Revenue Growth -8.68% n/a n/a
Other, Europe Revenue 3.11B 2.71B n/a
Other, Europe Revenue Growth +14.93% n/a n/a
Spain Revenue 847.00M 738.00M n/a
Spain Revenue Growth +14.77% n/a n/a
Sweden Revenue 1.70B 1.72B n/a
Sweden Revenue Growth -0.99% n/a n/a
The Americas Revenue 20.77B 20.13B n/a
The Americas Revenue Growth +3.20% n/a n/a
Uk Revenue 3.37B 996.00M n/a
Uk Revenue Growth +238.15% n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 5.29B 5.06B 4.63B 3.98B 4.93B 5.12B 4.19B 4.78B 3.29B 4.81B 4.96B 5.24B 2.99B 3.20B 3.03B 3.32B 2.27B 2.74B 2.81B 3.09B 3.25B 3.02B 2.59B 2.69B 2.50B 2.63B 2.54B 3.16B 2.57B 2.43B 2.38B 1.47B 2.48B 3.14B 2.65B 2.77B 2.76B 3.05B 2.88B
Selling, General, and Administrative Revenue Growth +4.49% +9.31% +16.24% -19.19% -3.67% +22.04% -12.23% +45.42% -31.70% -3.12% -5.27% +75.52% -6.72% +5.71% -8.77% +46.21% -17.12% -2.39% -9.25% -4.86% +7.47% +16.67% -3.75% +7.89% -5.28% +3.82% -19.76% +22.93% +5.88% +2.23% +61.81% -40.74% -21.13% +18.69% -4.30% +0.33% -9.57% +6.05% n/a
Research and Development Revenue 3.12B 3.01B 2.78B 3.07B 2.58B 2.67B 2.61B 2.63B 2.36B 2.55B 2.13B 2.58B 2.15B 1.83B 1.71B 1.72B 1.45B 1.39B 1.39B 2.07B 1.33B 1.36B 1.27B 2.01B 1.28B 1.36B 1.28B 1.55B 1.40B 1.35B 1.45B 1.54B 1.40B 1.47B 1.48B 1.75B 1.43B 1.47B 1.36B
Research and Development Revenue Growth +3.56% +8.08% -9.44% +18.92% -3.11% +2.14% -0.53% +11.37% -7.42% +19.36% -17.45% +20.07% +17.66% +6.77% -0.35% +18.31% +4.61% +0.07% -33.01% +56.02% -2.06% +7.11% -37.08% +57.31% -6.09% +6.49% -17.54% +10.47% +4.08% -7.16% -5.83% +10.06% -4.30% -1.01% -15.23% +22.18% -2.52% +8.11% n/a
Sales and Marketing Revenue 145.00M 132.00M 135.00M 17.83B 4.93B 5.12B 4.19B 4.78B 3.29B 4.81B 4.96B 5.24B 2.99B 3.20B 3.03B 3.32B 2.27B 2.74B 2.81B 3.09B 3.25B 3.02B 2.59B 2.69B 2.50B 2.63B 2.54B 3.16B 2.57B 2.43B 2.38B 1.47B 2.48B 3.14B 2.65B 2.77B 2.76B 3.05B 2.88B
Sales and Marketing Revenue Growth +9.85% -2.22% -99.24% +261.70% -3.67% +22.04% -12.23% +45.42% -31.70% -3.12% -5.27% +75.52% -6.72% +5.71% -8.77% +46.21% -17.12% -2.39% -9.25% -4.86% +7.47% +16.67% -3.75% +7.89% -5.28% +3.82% -19.76% +22.93% +5.88% +2.23% +61.81% -40.74% -21.13% +18.69% -4.30% +0.33% -9.57% +6.05% n/a

Create Price Alert on AZN

Your price alert will notify you when the stock price is above 65.31.

Add to Watchlist